Sionna Therapeutics Inc
NASDAQ:SION
Cash Flow Statement
Cash Flow Statement
Sionna Therapeutics Inc
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Operating Cash Flow | |||||
| Net Income |
(62)
|
(78)
|
(96)
|
(71)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
4
|
6
|
9
|
12
|
|
| Other Non-Cash Items |
11
|
13
|
15
|
8
|
|
| Change in Working Capital |
(3)
|
(5)
|
(7)
|
1
|
|
| Cash from Operating Activities |
(53)
N/A
|
(69)
-31%
|
(87)
-26%
|
(61)
+30%
|
|
| Investing Cash Flow | |||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(127)
|
(268)
|
(291)
|
(126)
|
|
| Cash from Investing Activities |
(127)
N/A
|
(268)
-111%
|
(291)
-9%
|
(126)
+57%
|
|
| Financing Cash Flow | |||||
| Net Issuance of Common Stock |
181
|
384
|
384
|
204
|
|
| Other |
(3)
|
0
|
0
|
(1)
|
|
| Cash from Financing Activities |
179
N/A
|
381
+113%
|
381
0%
|
203
-47%
|
|
| Change in Cash | |||||
| Net Change in Cash |
(1)
N/A
|
44
N/A
|
2
-94%
|
15
+512%
|
|
| Free Cash Flow | |||||
| Free Cash Flow |
(53)
N/A
|
(69)
-31%
|
(87)
-26%
|
(62)
+29%
|
|